BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Godtfredsen NS, Lucht H, Prescott E, Sørensen TI, Grønbaek M. A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol 2004;57:858-63. [PMID: 15485739 DOI: 10.1016/j.jclinepi.2003.11.015] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Rödel F, Fournier C, Wiedemann J, Merz F, Gaipl US, Frey B, Keilholz L, Seegenschmiedt MH, Rödel C, Hehlgans S. Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases. Front Immunol 2017;8:519. [PMID: 28515727 DOI: 10.3389/fimmu.2017.00519] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
2 Townley WA, Baker R, Sheppard N, Grobbelaar AO. Dupuytren's contracture unfolded. BMJ 2006;332:397-400. [PMID: 16484265 DOI: 10.1136/bmj.332.7538.397] [Cited by in Crossref: 97] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
3 Becker K, Tinschert S, Lienert A, Bleuler PE, Staub F, Meinel A, Rößler J, Wach W, Hoffmann R, Kühnel F, Damert HG, Nick HE, Spicher R, Lenze W, Langer M, Nürnberg P, Hennies HC. The importance of genetic susceptibility in Dupuytren's disease. Clin Genet 2015;87:483-7. [PMID: 24749973 DOI: 10.1111/cge.12410] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
4 Pratt AL, Byrne G. The lived experience of Dupuytren’s disease of the hand. Journal of Clinical Nursing 2009;18:1793-802. [DOI: 10.1111/j.1365-2702.2008.02692.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
5 Dutta A, Jayasinghe G, Deore S, Wahed K, Bhan K, Bakti N, Singh B. Dupuytren's Contracture - Current Concepts. J Clin Orthop Trauma 2020;11:590-6. [PMID: 32684695 DOI: 10.1016/j.jcot.2020.03.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kuo RYL, Ng M, Prieto-Alhambra D, Furniss D. Dupuytren's Disease Predicts Increased All-Cause and Cancer-Specific Mortality: Analysis of a Large Cohort from the U.K. Clinical Practice Research Datalink. Plast Reconstr Surg 2020;145:574e-82e. [PMID: 32097318 DOI: 10.1097/PRS.0000000000006551] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Kragelund C, Jensen SB, Hansen Cand Scient C, Broesen K, Torpet LA, Reibel J. Subgrouping of patients with oral lichen planus according to cytochrome P450 enzyme phenotype and genotype. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:469-74. [PMID: 25240994 DOI: 10.1016/j.oooo.2014.06.008] [Reference Citation Analysis]
8 Lanting R, van den Heuvel ER, Westerink B, Werker PMN. Prevalence of Dupuytren disease in The Netherlands. Plast Reconstr Surg 2013;132:394-403. [PMID: 23897337 DOI: 10.1097/PRS.0b013e3182958a33] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 5.4] [Reference Citation Analysis]
9 Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (N Y) 2009;4:256-69. [PMID: 19145463 DOI: 10.1007/s11552-008-9160-9] [Cited by in Crossref: 131] [Cited by in F6Publishing: 85] [Article Influence: 10.1] [Reference Citation Analysis]
10 Shchudlo N, Varsegova T, Stupina T, Dolganova T, Shchudlo M, Shihaleva N, Kostin V. Assessment of palmar subcutaneous tissue vascularization in patients with Dupuytren’s contracture. World J Orthop 2018; 9(9): 130-137 [PMID: 30254969 DOI: 10.5312/wjo.v9.i9.130] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Grazina R, Teixeira S, Ramos R, Sousa H, Ferreira A, Lemos R. Dupuytren's disease: where do we stand? EFORT Open Rev 2019;4:63-9. [PMID: 30931150 DOI: 10.1302/2058-5241.4.180021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bayat A, Cunliffe E, Mcgrouther D. Assessment of clinical severity in Dupuytren's disease. British Journal of Hospital Medicine 2007;68:604-9. [DOI: 10.12968/hmed.2007.68.11.27683] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
13 Hnanicek J, Cimburova M, Putova I, Svoboda S, Stritesky J, Kratka K, Sosna B, Horak J. Lack of association of iron metabolism and Dupuytren's disease. J Eur Acad Dermatol Venereol 2008;22:476-80. [PMID: 18194242 DOI: 10.1111/j.1468-3083.2007.02506.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
14 Tajika T, Kobayashi T, Kaneko T, Tsunoda D, Tsunoda K, Sutou T, Yamamoto A, Takagishi K. Epidemiological study for personal risk factors and quality of life related to Dupuytren's disease in a mountain village of Japan. J Orthop Sci 2014;19:64-70. [PMID: 24129389 DOI: 10.1007/s00776-013-0478-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
15 Brazzelli M, Cruickshank M, Tassie E, McNamee P, Robertson C, Elders A, Fraser C, Hernandez R, Lawrie D, Ramsay C. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation. Health Technol Assess 2015;19:1-202. [PMID: 26524616 DOI: 10.3310/hta19900] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
16 Descatha A, Carton M, Mediouni Z, Dumontier C, Roquelaure Y, Goldberg M, Zins M, Leclerc A. Association among work exposure, alcohol intake, smoking and Dupuytren's disease in a large cohort study (GAZEL). BMJ Open 2014;4:e004214. [PMID: 24477316 DOI: 10.1136/bmjopen-2013-004214] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
17 Mohammadi A, Abegaz F, van den Heuvel E, Wit EC. Bayesian modelling of Dupuytren disease by using Gaussian copula graphical models. J R Stat Soc C 2017;66:629-45. [DOI: 10.1111/rssc.12171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
18 Dinis-oliveira RJ, Magalhães T, Moreira R, Proença JB, Pontes H, Santos A, Duarte JA, Carvalho F. Clinical and forensic signs related to ethanol abuse: a mechanistic approach. Toxicology Mechanisms and Methods 2013;24:81-110. [DOI: 10.3109/15376516.2013.869782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lucas G, Brichet A, Roquelaure Y, Leclerc A, Descatha A. Dupuytren's disease: personal factors and occupational exposure. Am J Ind Med 2008;51:9-15. [PMID: 18033693 DOI: 10.1002/ajim.20542] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
20 Murínová L, Perečinský S, Jančová A, Murín P, Legáth Ľ. Is Dupuytren's disease an occupational illness? Occup Med (Lond) 2021;71:28-33. [PMID: 33420499 DOI: 10.1093/occmed/kqaa211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Karbowiak M, Holme T, Khan K, Mohan A. Dupuytren's disease. BMJ 2021;373:n1308. [PMID: 34088710 DOI: 10.1136/bmj.n1308] [Reference Citation Analysis]
22 Seyhan H, Stromps JP, Demir E, Fuchs PC, Kopp J. Vitamin D deficiency may stimulate fibroblasts in Dupuytren's disease via mitochondrial increased reactive oxygen species through upregulating transforming growth factor-β1. Med Hypotheses 2018;116:40-1. [PMID: 29857907 DOI: 10.1016/j.mehy.2018.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
23 Engstrand C, Borén L, Liedberg G. Evaluation of Activity Limitation and Digital Extension in Dupuytren's Contracture Three Months after Fasciectomy and Hand Therapy Interventions. Journal of Hand Therapy 2009;22:21-7. [DOI: 10.1016/j.jht.2008.08.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
24 Hu FZ, Nystrom A, Ahmed A, Palmquist M, Dopico R, Mossberg I, Gladitz J, Rayner M, Post JC, Ehrlich GD, Preston RA. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet 2005;68:424-9. [PMID: 16207209 DOI: 10.1111/j.1399-0004.2005.00504.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
25 O'Gorman DB, Vi L, Gan BS. Molecular mechanisms and treatment strategies for Dupuytren's disease. Ther Clin Risk Manag 2010;6:383-90. [PMID: 20856684 DOI: 10.2147/tcrm.s9165] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Descatha A, Jauffret P, Chastang JF, Roquelaure Y, Leclerc A. Should we consider Dupuytren's contracture as work-related? A review and meta-analysis of an old debate. BMC Musculoskelet Disord 2011;12:96. [PMID: 21575231 DOI: 10.1186/1471-2474-12-96] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
27 Becker K, Siegert S, Toliat MR, Du J, Casper R, Dolmans GH, Werker PM, Tinschert S, Franke A, Gieger C, Strauch K, Nothnagel M, Nürnberg P, Hennies HC; German Dupuytren Study Group. Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease. PLoS One 2016;11:e0158101. [PMID: 27467239 DOI: 10.1371/journal.pone.0158101] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
28 Mansur HG, Oliveira ER, Gonçalves CB. Epidemiological analysis of patients with Dupuytren's disease. Rev Bras Ortop 2018;53:10-4. [PMID: 29367900 DOI: 10.1016/j.rboe.2017.12.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Satish L, Palmer B, Liu F, Papatheodorou L, Rigatti L, Baratz ME, Kathju S. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat. BMC Musculoskelet Disord 2015;16:138. [PMID: 26049932 DOI: 10.1186/s12891-015-0597-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 Nordenskjöld J, Lauritzson A, Waldén M, Kopylov P, Atroshi I. Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial. BMJ Open 2019;9:e024424. [PMID: 30808670 DOI: 10.1136/bmjopen-2018-024424] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Carr L, Michelotti B, Brgoch M, Hauck R, Ingraham J. Dupuytren Disease Management Trends: A Survey of Hand Surgeons. Hand (N Y) 2020;15:97-102. [PMID: 30043624 DOI: 10.1177/1558944718787281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Wei DH, Strauch RJ. Smoking and Hand Surgery. The Journal of Hand Surgery 2013;38:176-9. [DOI: 10.1016/j.jhsa.2012.08.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
33 Zdilla MJ. The Hand of Sabazios: Evidence of Dupuytren’s Disease in Antiquity and the Origin of the Hand of Benediction. J Hand Surg Asian-Pac Vol 2017;22:403-10. [DOI: 10.1142/s0218810417970012] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Rydberg M, Zimmerman M, Löfgren JP, Gottsäter A, Nilsson PM, Melander O, Dahlin LB. Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years. Sci Rep 2021;11:14669. [PMID: 34282190 DOI: 10.1038/s41598-021-94025-7] [Reference Citation Analysis]
35 Warwick D, Arandes-Renú JM, Pajardi G, Witthaut J, Hurst LC. Collagenase Clostridium histolyticum: emerging practice patterns and treatment advances. J Plast Surg Hand Surg 2016;50:251-61. [PMID: 27050718 DOI: 10.3109/2000656X.2016.1159568] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
36 Broekstra DC, Lanting R, Werker PM, van den Heuvel ER. Intra- and inter-observer agreement on diagnosis of Dupuytren disease, measurements of severity of contracture, and disease extent. Manual Therapy 2015;20:580-6. [DOI: 10.1016/j.math.2015.01.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
37 Maravic M, Lasbleiz S, Roulot E, Beaudreuil J. Hospitalization for Dupuytren's disease: a French national descriptive analysis, 2002 to 2009. Orthop Traumatol Surg Res 2014;100:589-92. [PMID: 25164352 DOI: 10.1016/j.otsr.2014.05.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
38 Loos B, Puschkin V, Horch RE. 50 years experience with Dupuytren's contracture in the Erlangen University Hospital--a retrospective analysis of 2919 operated hands from 1956 to 2006. BMC Musculoskelet Disord 2007;8:60. [PMID: 17610744 DOI: 10.1186/1471-2474-8-60] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
39 Kragelund C, Hansen C, Torpet L, Nauntofte B, Brøsen K, Pedersen A, Buchwald C, Therkildsen M, Reibel J. Expression of two drug-metabolizing cytochrome P450-enzymes in human salivary glands. Oral Diseases 2008;14:533-40. [DOI: 10.1111/j.1601-0825.2007.01415.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
40 Satish L, LaFramboise WA, Johnson S, Vi L, Njarlangattil A, Raykha C, Krill-Burger JM, Gallo PH, O'Gorman DB, Gan BS, Baratz ME, Ehrlich GD, Kathju S. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture. BMC Med Genomics 2012;5:15. [PMID: 22559715 DOI: 10.1186/1755-8794-5-15] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
41 Pervulesko N, Schöffl V, Gormasz C. Evaluation of a self-diagnostic tool for Dupuytren's disease in rock climbers. Hand Therapy 2011;16:45-8. [DOI: 10.1258/ht.2010.010027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Overbeek JA, Penning-van Beest FJ, Heintjes EM, Gerber RA, Cappelleri JC, Hovius SE, Herings RM. Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands. BMC Res Notes 2011;4:402. [PMID: 21992150 DOI: 10.1186/1756-0500-4-402] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
43 Riesmeijer SA, Werker PMN, Nolte IM. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants. Eur J Hum Genet 2019;27:1876-84. [PMID: 31363186 DOI: 10.1038/s41431-019-0483-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Mathieu S, Naughton G, Descatha A, Soubrier M, Dutheil F. Dupuytren's Disease and exposure to vibration: Systematic review and Meta-analysis. Joint Bone Spine 2020;87:203-7. [PMID: 32061740 DOI: 10.1016/j.jbspin.2020.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 2010;6:715-26. [DOI: 10.1038/nrrheum.2010.180] [Cited by in Crossref: 101] [Cited by in F6Publishing: 67] [Article Influence: 8.4] [Reference Citation Analysis]
46 Haines A, Levis C, Goldsmith CH, Kaur M, Duku E, Wells R, Walter SD, Rook C, Stock S, Liss G, Murphy J, Thoma A. Dupuytren's contracture and handwork: A case-control study. Am J Ind Med 2017;60:724-33. [DOI: 10.1002/ajim.22736] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
47 Williams LM, McCann FE, Cabrita MA, Layton T, Cribbs A, Knezevic B, Fang H, Knight J, Zhang M, Fischer R, Bonham S, Steenbeek LM, Yang N, Sood M, Bainbridge C, Warwick D, Harry L, Davidson D, Xie W, Sundstrӧm M, Feldmann M, Nanchahal J. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300. Proc Natl Acad Sci U S A 2020;117:20753-63. [PMID: 32759223 DOI: 10.1073/pnas.2004281117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
48 Alser OH, Kuo RYL, Furniss D. Nongenetic Factors Associated with Dupuytren's Disease: A Systematic Review. Plast Reconstr Surg 2020;146:799-807. [PMID: 32970002 DOI: 10.1097/PRS.0000000000007146] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]